当前位置:首页 - 行情中心 - 宣泰医药(688247) - 财务分析 - 现金流量表

宣泰医药

(688247)

  

流通市值:45.74亿  总市值:45.74亿
流通股本:4.53亿   总股本:4.53亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金247,311,067.48119,281,470.42503,656,812.62373,652,298.04
  收到的税费返还1,123,790.67187,542.18,246,043.055,433,086.3
  收到其他与经营活动有关的现金11,094,635.62,043,594.3413,485,315.356,636,359.26
  经营活动现金流入小计259,529,493.75121,512,606.86525,388,171.02385,721,743.6
  购买商品、接受劳务支付的现金95,448,732.9541,393,452.64239,801,571.84165,502,403.68
  支付给职工以及为职工支付的现金48,353,898.1426,231,261.12104,696,238.8883,495,887.97
  支付的各项税费8,941,010.734,707,657.728,254,774.1926,429,350.32
  支付其他与经营活动有关的现金21,737,970.329,002,876.7157,309,727.832,853,322.56
  经营活动现金流出小计174,481,612.1481,335,248.17430,062,312.71308,280,964.53
  经营活动产生的现金流量净额85,047,881.6140,177,358.6995,325,858.3177,440,779.07
二、投资活动产生的现金流量:
  收回投资收到的现金404,000,000165,000,0001,962,000,0001,498,000,000
  取得投资收益收到的现金2,857,527.711,248,724.659,636,920.897,141,803.21
  投资活动现金流入小计406,857,527.71166,248,724.651,971,636,920.891,505,141,803.21
  购建固定资产、无形资产和其他长期资产支付的现金14,002,390.097,349,996.3941,558,417.0932,313,415.26
  投资支付的现金720,000,000460,000,0001,813,100,0001,507,100,000
  投资活动现金流出小计734,002,390.09467,349,996.391,854,658,417.091,539,413,415.26
  投资活动产生的现金流量净额-327,144,862.38-301,101,271.74116,978,503.8-34,271,612.05
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金6,250,985.66-27,838,140.0318,374,090.72
  支付其他与筹资活动有关的现金33,868.7216,840.868,298.868,298.8
  筹资活动现金流出小计6,284,854.3816,840.827,906,438.8318,442,389.52
  筹资活动产生的现金流量净额-6,284,854.38-16,840.8-27,906,438.83-18,442,389.52
四、汇率变动对现金及现金等价物的影响-3,105,796.08-2,069,984.25-3,294,230.88-1,412,439.12
五、现金及现金等价物净增加额-251,487,631.23-263,010,738.1181,103,692.423,314,338.38
  加:期初现金及现金等价物余额406,889,473.83406,889,473.83225,785,781.43225,785,781.43
  期末现金及现金等价物余额155,401,842.6143,878,735.73406,889,473.83249,100,119.81
补充资料:
  净利润29,701,777.95-47,482,814.69-
  资产减值准备891,116.42-17,539,733.26-
  固定资产和投资性房地产折旧13,752,851.48-25,102,090.17-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧13,752,851.48-25,102,090.17-
  无形资产摊销3,341,621.06-6,729,811.12-
  长期待摊费用摊销167,938.33-494,046.58-
  递延收益摊销-4,377,831.04---
  固定资产报废损失172.27-363,521.15-
  公允价值变动损失---1,341,275.35-
  财务费用3,073,573-3,274,781.43-
  投资损失-7,814,596.51--9,294,077.87-
  递延所得税470,979.7-173,175.03-
  其中:递延所得税资产减少540,012.37-318,487.85-
    递延所得税负债增加-69,032.67--145,312.82-
  存货的减少-5,185,415.61-14,434,028.17-
  经营性应收项目的减少31,500,759.8-22,885,324.76-
  经营性应付项目的增加20,742,352--17,747,726.24-
  其他1,739,160.39--16,290,725.38-
  现金的期末余额155,401,842.6-406,889,473.83-
  减:现金的期初余额406,889,473.83-225,785,781.43-
  现金及现金等价物的净增加额-251,487,631.23-181,103,692.4-
公告日期2026-08-282026-04-302026-04-302025-10-31
审计意见(境内)标准无保留意见
TOP↑